Subcutaneous (SC) set with low flow resistance 24 G, 90° bent needle, winged hub, 24” tubing, transparent dressing with tape, and 0.9 ml priming volume. Refer to drug manufacturer’s package insert for dosing instructions.

Subcutaneous (SC) set with low flow resistance 24 G, 90° bent needle, winged hub, 24” tubing, transparent dressing with tape, and 0.9 ml priming volume. Refer to drug manufacturer’s package insert for dosing instructions.

Subcutaneous (SC) set with low flow resistance 24 G, 90° bent needle, winged hub, 24” tubing, transparent dressing with tape, and 0.9 ml priming volume. Refer to drug manufacturer’s package insert for dosing instructions.

Dual vial unit containing vial with 10 g of Immune Globulin Infusion 10% (Human) (100 mg/mL protein) and vial with 800 units of Recombinant Human Hyaluronidase (160 U/mL), for subcutaneous administration; physician/patient inserts

Dual vial unit containing vial with 20 g of Immune Globulin Infusion 10% (Human) (100 mg/mL protein) and vial with 1600 units of Recombinant Human Hyaluronidase (160 U/mL), for subcutaneous administration; physician/patient inserts

Dual vial unit containing vial with 30 g of Immune Globulin Infusion 10% (Human) (100 mg/mL protein) and vial with 2400 units of Recombinant Human Hyaluronidase (160 U/mL), for subcutaneous administration; physician/patient inserts

Dual vial unit containing vial with 5 g of Immune Globulin Infusion 10% (Human) (100 mg/mL protein) and vial with 400 units of Recombinant Human Hyaluronidase (160 U/mL), for subcutaneous administration; physician/patient inserts

Dual vial unit containing vial with 2.5 g of Immune Globulin Infusion 10% (Human) (100 mg/mL protein) and vial with 200 units of Recombinant Human Hyaluronidase (160 U/mL), for subcutaneous administration; physician/patient inserts